Combinations of PD-1 Antagonists and Benzo[b]thiophene STING Agonists for Cancer Treatment
摘要:
Therapeutic combinations that comprise at least one antagonist of the Programmed Death 1 receptor (PD-1) and at least one benzo[b]thiophene compound that activates the Stimulator of Interferon Genes (STING) pathway are disclosed herein. Also disclosed is the use of such therapeutic combinations for the treatment of cancers.
信息查询
0/0